You are currently on the new version of our website. Access the old version .

122 Results Found

  • Article
  • Open Access
20 Citations
3,869 Views
13 Pages

Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris

  • Drahomira Holmannova,
  • Pavel Borsky,
  • Lenka Borska,
  • Ctirad Andrys,
  • Kvetoslava Hamakova,
  • Vit Rehacek,
  • Tereza Svadlakova,
  • Andrea Malkova,
  • Martin Beranek and
  • Zdenek Fiala
  • + 1 author

Background: Psoriasis is a pathological condition characterized by immune system dysfunction and inflammation. Patients with psoriasis are more likely to develop a wide range of disorders associated with inflammation. Serum levels of various substanc...

  • Article
  • Open Access
10 Citations
2,450 Views
12 Pages

Clusterin Plasma Concentrations Are Decreased in Sepsis and Inversely Correlated with Established Markers of Inflammation

  • Eray Yagmur,
  • Samira Abu Jhaisha,
  • Lukas Buendgens,
  • Nadezhda Sapundzhieva,
  • Jonathan F. Brozat,
  • Philipp Hohlstein,
  • Maike R. Pollmanns,
  • Ger H. Koek,
  • Ralf Weiskirchen and
  • Alexander Koch
  • + 2 authors

1 December 2022

Clusterin is a multifunctional protein that is recognized to mediate cellular stress response associated with organ failure, systemic inflammation, and metabolic alterations. The aim of this study was to determine the value of clusterin as a clinical...

  • Review
  • Open Access
6 Citations
3,061 Views
17 Pages

Clusterin Expression in Colorectal Carcinomas

  • Teresa Téllez,
  • Desirée Martin-García,
  • Maximino Redondo and
  • Marilina García-Aranda

27 September 2023

Colorectal cancer is the third most diagnosed cancer, behind only breast and lung cancer. In terms of overall mortality, it ranks second due to, among other factors, problems with screening programs, which means that one of the factors that directly...

  • Article
  • Open Access
28 Citations
5,533 Views
12 Pages

Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway

  • Hye-Young Seo,
  • So-Hee Lee,
  • Ji-Ha Lee,
  • Yu Na Kang,
  • Young-Keun Choi,
  • Jae Seok Hwang,
  • Keun-Gyu Park,
  • Byoung Kuk Jang and
  • Mi Kyung Kim

14 November 2019

Clusterin is a glycoprotein that is expressed in most human tissues and found in body fluids. In our previous studies we demonstrated that clusterin has a protective effect against hepatic lipid accumulation and renal fibrosis; however, the role of c...

  • Review
  • Open Access
2,187 Views
20 Pages

Clusterin Regulates the Mechanisms of Neuroinflammation and Neuronal Circuit Impairment in Alzheimer’s Disease

  • Yihang Yu,
  • Chunjian Wang,
  • Binbin Wang,
  • Xuelin Wang,
  • Qain Zhao,
  • Yan Yan and
  • Xiaoyun Liu

Alzheimer’s disease (AD) is a neurodegenerative disease with a multifaceted pathogenesis, which remains elusive, seriously affecting the quality of life of elderly patients and placing a heavy burden on affected individuals, their families, and...

  • Review
  • Open Access
5 Citations
3,028 Views
18 Pages

Therapeutic Potential of Clusterin Inhibition in Human Cancer

  • Desirée Martín-García,
  • Marilina García-Aranda and
  • Maximino Redondo

10 April 2024

Clusterin (CLU) protein is involved in various pathophysiological processes including carcinogenesis and tumor progression. In recent years, the role of the secretory isoform has been demonstrated in tumor cells, where it inhibits apoptosis and favor...

  • Abstract
  • Open Access
2 Citations
2,555 Views
2 Pages

Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection

  • Theodore Bungon,
  • Carrie Haslam,
  • Samar Damiati,
  • Benjamin O’Driscoll,
  • Toby Whitley,
  • Paul Davey,
  • Giuliano Siligardi,
  • Jerome Charmet and
  • Shakil A. Awan

5 November 2020

We report on the fabrication and characterisation of Graphene field-effect transistor (GFET) Biosensors for detecting clusterin, a prominent protein biomarker of Alzheimer’s disease (AD). There are approximately 54 million people currently living wit...

  • Article
  • Open Access
1 Citations
1,287 Views
19 Pages

Background/Objectives: Glioblastoma is an aggressive brain tumor with limited treatment options and significant resistance to conventional therapies. Methods: In this study, we explored the effects of combining curcumin treatment with clusterin inhib...

  • Article
  • Open Access
1 Citations
811 Views
15 Pages

3 October 2025

Clusterin plays an important role in carcinogenesis and serves as an important diagnostic biomarker of various clinical conditions. This work describes an application of a surface-enhanced Raman scattering (SERS)-based immunoassay using Al foil subst...

  • Article
  • Open Access
1 Citations
1,384 Views
28 Pages

30 May 2025

Clusterin is one of the many known proteins implicated in cancer chemoresistance, which hinders the effectiveness of chemotherapy. This study aimed to design novel inhibitors targeting clusterin using fragment-based drug discovery (FBDD). This approa...

  • Article
  • Open Access
7 Citations
3,894 Views
15 Pages

Early Elevation of Systemic Plasma Clusterin after Reperfused Acute Myocardial Infarction in a Preclinical Porcine Model of Ischemic Heart Disease

  • Denise Traxler,
  • Andreas Spannbauer,
  • Patrick Einzinger,
  • Julia Mester-Tonczar,
  • Dominika Lukovic,
  • Johannes Winkler,
  • Katrin Zlabinger,
  • Alfred Gugerell,
  • Ljubica Mandic and
  • Noemi Pavo

Clusterin exerts anti-inflammatory, cytoprotective and anti-apoptotic effects. Both an increase and decrease of clusterin in acute myocardial infarction (AMI) has been reported. We aimed to clarify the role of clusterin as a systemic biomarker in AMI...

  • Article
  • Open Access
10 Citations
3,483 Views
12 Pages

Monocyte Chemoattractant Protein-1 (MCP-1), Activin-A and Clusterin in Children and Adolescents with Obesity or Type-1 Diabetes Mellitus

  • Eirini Kostopoulou,
  • Dimitra Kalavrizioti,
  • Panagiota Davoulou,
  • Evangelos Papachristou,
  • Xenophon Sinopidis,
  • Sotirios Fouzas,
  • Theodore Dassios,
  • Despoina Gkentzi,
  • Stavroula Ioanna Kyriakou and
  • Marios Papasotiriou
  • + 4 authors

19 February 2024

Inflammation plays a crucial role in diabetes and obesity through macrophage activation. Macrophage chemoattractant protein-1 (MCP-1), activin-A, and clusterin are chemokines with known roles in diabetes and obesity. The aim of this study is to inves...

  • Article
  • Open Access
5 Citations
2,257 Views
12 Pages

17 October 2022

Clusterin is a glycoprotein present at high concentrations in many extracellular fluids, including semen. Its increased expression accompanies disorders associated with extracellular amyloid fibril accumulation such as Alzheimer’s disease. Clus...

  • Article
  • Open Access
5 Citations
5,284 Views
11 Pages

A Clinical Study on Urinary Clusterin and Cystatin B in Dogs with Spontaneous Acute Kidney Injury

  • Emilia Gordin,
  • Sanna Viitanen,
  • Daniel Gordin,
  • Donald Szlosek,
  • Sarah Peterson,
  • Thomas Spillmann and
  • Mary Anna Labato

Novel biomarkers are needed in diagnosing reliably acute kidney injury (AKI) in dogs and in predicting morbidity and mortality after AKI. Our hypothesis was that two novel tubular biomarkers, urinary clusterin (uClust) and cystatin B (uCysB), are ele...

  • Review
  • Open Access
1 Citations
1,401 Views
13 Pages

The Emerging Role of the Molecular Chaperone Clusterin in Parkinson’s Disease

  • Giulia Carini,
  • Salihu Mohammed,
  • Alice Filippini,
  • Ileana Ramazzina and
  • Isabella Russo

Clusterin (CLU) is a heterodimeric, ATP-independent molecular chaperone that exhibits high expression in the brain. While CLU primarily functions in the extracellular environment, its chaperone activity in the intracellular compartment under differen...

  • Review
  • Open Access
7 Citations
4,545 Views
27 Pages

Parkinson’s disease (PD)—a neurodegenerative disorder (NDD) characterized by progressive destruction of dopaminergic neurons within the substantia nigra of the brain—is associated with the formation of Lewy bodies containing mainly...

  • Feature Paper
  • Article
  • Open Access
1,337 Views
14 Pages

5 February 2025

Immunohistochemically, ameloblastomas often express CD56; however, novel neuroendocrine markers such as synaptophysin (SYP), insulinoma-associated protein 1 (INSM1), and chromogranin A (CgA) remain unexplored. We analyzed 36 ameloblastoma specimens f...

  • Communication
  • Open Access
35 Citations
9,174 Views
12 Pages

Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer’s Biomarker

  • Kamrul Islam,
  • Samar Damiati,
  • Jagriti Sethi,
  • Ahmed Suhail and
  • Genhua Pan

20 January 2018

Clusterin (CLU) has been associated with the clinical progression of Alzheimer’s disease (AD) and described as a potential AD biomarker in blood plasma. Due to the enormous attention given to cerebrospinal fluid (CSF) biomarkers for the past couple o...

  • Article
  • Open Access
24 Citations
3,721 Views
18 Pages

The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process

  • Chiara Lenzi,
  • Ileana Ramazzina,
  • Isabella Russo,
  • Alice Filippini,
  • Saverio Bettuzzi and
  • Federica Rizzi

29 September 2020

Parkinson’s Disease (PD) is a progressive neurodegenerative disease characterized by the presence of proteinaceous aggregates of αSynuclein (αSyn) in the dopaminergic neurons. Chaperones are key components of the proteostasis networ...

  • Article
  • Open Access
17 Citations
3,637 Views
14 Pages

Clusterin Deficiency Exacerbates Hyperoxia-Induced Acute Lung Injury

  • Jung Yeon Hong,
  • Mi Na Kim,
  • Eun Gyul Kim,
  • Jae Woo Lee,
  • Hye Rin Kim,
  • Soo Yeon Kim,
  • Soon Min Lee,
  • Yoon Hee Kim,
  • Kyung Won Kim and
  • Myung Hyun Sohn

19 April 2021

Exposure to high oxygen concentrations leads to generation of excessive reactive oxygen species, causing cellular injury and multiple organ dysfunctions and is associated with a high mortality rate. Clusterin (CLU) is a heterodimeric glycoprotein tha...

  • Review
  • Open Access
5 Citations
3,207 Views
13 Pages

Clusterin and Its Isoforms in Oral Squamous Cell Carcinoma and Their Potential as Biomarkers: A Comprehensive Review

  • Qinyi Zhang,
  • Jun Yao Teow,
  • Jesinda Pauline Kerishnan,
  • Adyani Azizah Abd Halim and
  • Yeng Chen

Oral squamous cell carcinoma (OSCC) is a prevalent type of head and neck cancer, ranked as the sixth most common cancer worldwide, accounting for approximately 300,000 new cases and 145,000 deaths annually. Early detection using biomarkers significan...

  • Article
  • Open Access
6 Citations
3,101 Views
10 Pages

Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis

  • Virginia Veronica Visconti,
  • Chiara Greggi,
  • Ida Cariati,
  • Beatrice Gasperini,
  • Ambra Mastrogregori,
  • Annalisa Botta and
  • Umberto Tarantino

7 April 2022

Clusterin (CLU) is a secreted heterodimeric glycoprotein expressed in all organism fluids as well as in the intracellular matrix that plays key roles in several pathological processes. Its recent involvement in muscle degeneration of osteoporotic pat...

  • Review
  • Open Access
16 Citations
5,446 Views
45 Pages

The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing

  • Christelle Gross,
  • Louis-Philippe Guérin,
  • Bianca G. Socol,
  • Lucie Germain and
  • Sylvain L. Guérin

24 August 2023

Clusterin (CLU) is a glycoprotein originally discovered in 1983 in ram testis fluid. Rapidly observed in other tissues, it was initially given various names based on its function in different tissues. In 1992, it was finally named CLU by consensus. N...

  • Article
  • Open Access
7 Citations
3,236 Views
16 Pages

Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis

  • Shaobo Huang,
  • Xu Li,
  • Weiqi Gu,
  • Xiaoyi Li,
  • Jingjing Zhao,
  • Jueheng Wu,
  • Junchao Cai,
  • Xianming Feng and
  • Tianyu Tao

17 May 2022

Clusterin (CLU) is a heterodimeric glycoprotein that has been detected in diverse human tissues and implicated in many cellular processes. Accumulating evidence indicates that the expression of secreted CLU correlates with the progression of cancers....

  • Article
  • Open Access
9 Citations
2,431 Views
16 Pages

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration

  • Xiaoyue Ren,
  • Chao Chang,
  • Teng Qi,
  • Pengyu Yang,
  • Yuanbo Wang,
  • Xiaorui Zhou,
  • Feng Guan and
  • Xiang Li

29 August 2023

Dysregulation of clusterin (CLU) has been demonstrated in many cancers and has been proposed as a regulator of carcinogenesis. However, the roles of CLU in gliomas remain unclear. The expression of CLU was assessed using TIMER2.0, GEPIA2, and R packa...

  • Systematic Review
  • Open Access
16 Citations
5,069 Views
16 Pages

The Role of Clusterin Transporter in the Pathogenesis of Alzheimer’s Disease at the Blood–Brain Barrier Interface: A Systematic Review

  • Muhammad Mazhar Fareed,
  • Maryam Qasmi,
  • Shaan Aziz,
  • Elisabeth Völker,
  • Carola Yvette Förster and
  • Sergey Shityakov

10 October 2022

Alzheimer’s disease (AD) is considered a chronic and debilitating neurological illness that is increasingly impacting older-age populations. Some proteins, including clusterin (CLU or apolipoprotein J) transporter, can be linked to AD, causing...

  • Article
  • Open Access
16 Citations
3,408 Views
24 Pages

Clusterin and Its Potential Regulatory microRNAs as a Part of Secretome for the Diagnosis of Abnormally Invasive Placenta: Accreta, Increta, and Percreta Cases

  • Angelika V. Timofeeva,
  • Ivan S. Fedorov,
  • Mariya M. Pirogova,
  • Oksana N. Vasilchenko,
  • Vitaliy V. Chagovets,
  • Larisa S. Ezhova,
  • Tatiana M. Zabelina,
  • Roman G. Shmakov and
  • Gennadiy T. Sukhikh

24 March 2021

Magnetic resonance imaging (MRI) and ultrasound methods used for the diagnosis of an abnormally invasive placenta (AIP) have a wide range of sensitivity (Se, 33–93%) and specificity (Sp, 71–100%) levels, which results in a high risk of unfavorable ma...

  • Article
  • Open Access
5 Citations
1,342 Views
12 Pages

14 October 2024

Objectives: The aim of this study was to investigate the circulating levels of asprosin, clusterin, zinc-alpha-2-glycoprotein (ZAG), nuclear factor-kappa B (NF-κB), and peroxisome proliferator-activated receptor-gamma (PPAR-γ) in patients...

  • Article
  • Open Access
13 Citations
4,245 Views
21 Pages

In this study we attempted to verify the hypothesis that the mevalonate pathway affects amyloid beta precursor protein (AβPP) processing and regulates clusterin protein levels. AβPP expression was monitored by green fluorescence (FL) and We...

  • Review
  • Open Access
9 Citations
3,776 Views
14 Pages

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health

  • Alexandru Laslo,
  • Laura Laslo,
  • Eliza-Mihaela Arbănași,
  • Alexandru-Andrei Ujlaki-Nagi,
  • Laura Chinezu,
  • Adrian Dumitru Ivănescu,
  • Emil-Marian Arbănași,
  • Roxana Octavia Cărare,
  • Bogdan Andrei Cordoș and
  • Klara Brînzaniuc

One of the hallmarks of Alzheimer’s disease (AD) is the deposition of amyloid-β (Aβ) within the extracellular spaces of the brain as plaques and along the blood vessels in the brain, a condition also known as cerebral amyloid angiopat...

  • Article
  • Open Access
9 Citations
3,428 Views
22 Pages

Contribution of the Transcription Factors Sp1/Sp3 and AP-1 to Clusterin Gene Expression during Corneal Wound Healing of Tissue-Engineered Human Corneas

  • Christelle Gross,
  • Gaëtan Le-Bel,
  • Pascale Desjardins,
  • Manel Benhassine,
  • Lucie Germain and
  • Sylvain L. Guérin

17 November 2021

In order to reduce the need for donor corneas, understanding of corneal wound healing and development of an entirely tissue-engineered human cornea (hTECs) is of prime importance. In this study, we exploited the hTEC to determine how deep wound heali...

  • Article
  • Open Access
3 Citations
1,852 Views
15 Pages

Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis—The Search for New Diagnostic Glycomarkers

  • Ewa Maria Kratz,
  • Monika Kacperczyk,
  • Izabela Kokot,
  • Agnieszka Piwowar,
  • Bogusława Konopska,
  • Renata Sokolik and
  • Lucyna Korman

5 December 2024

Psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are connective tissue autoimmune diseases. The present study aimed to check whether serum clusterin (CLU) concentration and its glycosylation pattern may be markers differentiating these disease...

  • Article
  • Open Access
236 Views
14 Pages

Diagnostic Value and Metabolic Association of Serum Clusterin in Women with Polycystic Ovary Syndrome

  • Dilara Sarıkaya Kurt,
  • Recep Taha Ağaoğlu,
  • Mehmet Ferdi Kıncı,
  • Tuğçe Sırma,
  • Ahmet Kurt,
  • Ramazan Erda Pay,
  • İsmail Burak Gültekin,
  • Hüseyin Levent Keskin and
  • Sezin Ertürk Aksakal

Background: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by hyperandrogenism, ovulatory dysfunction, and an increased prevalence of metabolic syndrome. Clusterin (CLU), a chaperone protein induced by cel...

  • Article
  • Open Access
7 Citations
7,989 Views
17 Pages

18 November 2014

Apoptosis, as a programmed cell death process, is essential for the maintenance of tissue function in organisms. Alteration of this process is linked to many diseases. Over-expression of clusterin (Clu) can antagonize apoptosis in various cells. Sel...

  • Article
  • Open Access
1 Citations
3,074 Views
18 Pages

Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy

  • Shravan K. Chintala,
  • Jinhong Pan,
  • Sandeep Satapathy,
  • Rebecca Condruti,
  • Zixuan Hao,
  • Pei-wen Liu,
  • Christian F. O’Conner,
  • Joseph T. Barr,
  • Mark R. Wilson and
  • M. Elizabeth Fini

There is a significant unmet need for therapeutics to treat ocular surface barrier damage, also called epitheliopathy, due to dry eye and related diseases. We recently reported that the natural tear glycoprotein CLU (clusterin), a molecular chaperone...

  • Article
  • Open Access
4 Citations
1,825 Views
14 Pages

Serum Clusterin Concentration and Its Glycosylation Changes as Potential New Diagnostic Markers of SARS-CoV-2 Infection and Recovery Process

  • Katarzyna Sołkiewicz,
  • Izabela Kokot,
  • Monika Kacperczyk,
  • Violetta Dymicka-Piekarska,
  • Justyna Dorf and
  • Ewa Maria Kratz

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Glycoprotein clusterin (CLU) has many functions such as phagocyte recruitment, complement system inhibition, apoptosis inhibition, hormone and lipid transport, as well as in the immune...

  • Article
  • Open Access
10 Citations
2,917 Views
28 Pages

13 September 2022

Nearly 30% of infertility cases are caused by male factor. This study aimed at checking the associations between the sialylation degree of glycoprotein clusterin (CLU) and levels of oxidative–antioxidant balance markers in infertile men. Using...

  • Article
  • Open Access
28 Citations
7,907 Views
14 Pages

23 August 2012

Secreted clusterin (sCLU) has been shown to be overexpressed in metastatic hepatocellular carcinoma (HCC) tissue, and its overexpression in HCC cells increases cell migration and the formation of liver metastatic tumor nodules in vivo. In this study,...

  • Article
  • Open Access
21 Citations
3,207 Views
11 Pages

Clusterin as a New Marker of Kidney Injury in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Pilot Study

  • Kinga Musiał,
  • Monika Augustynowicz,
  • Izabella Miśkiewicz-Migoń,
  • Krzysztof Kałwak,
  • Marek Ussowicz and
  • Danuta Zwolińska

11 August 2020

Background and aims: The markers of renal damage defining subclinical AKI are not widely used in children undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). The aim of the study was to evaluate serum and urinary clusterin as in...

  • Article
  • Open Access
16 Citations
4,688 Views
19 Pages

Yellow Chaste Weed and Its Components, Apigenin and Galangin, Affect Proliferation and Oxidative Stress in Blue Light-Irradiated HaCaT Cells

  • Jung Yoen Park,
  • See-Hyoung Park,
  • Sae Woong Oh,
  • Kitae Kwon,
  • Eunbi Yu,
  • Seoyoung Choi,
  • Seoyoun Yang,
  • Su Bin Han,
  • Kwangsun Jung and
  • Jongsung Lee
  • + 1 author

13 March 2022

While harmful effects of blue light on skin cells have been recently reported, there are few studies regarding natural products that alleviate its negative effects. Therefore, we investigated ameliorating effects of yellow chaste weed (YCW) (Helichry...

  • Review
  • Open Access
19 Citations
4,511 Views
15 Pages

24 December 2020

Evidence is presented herein supporting the potential of the natural homeostatic glycoprotein CLU (clusterin) as a novel therapeutic for the treatment of dry eye. This idea began with the demonstration that matrix metalloproteinase MMP9 is required f...

  • Article
  • Open Access
9 Citations
2,946 Views
15 Pages

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma

  • Ombretta Repetto,
  • Laura Caggiari,
  • Mariangela De Zorzi,
  • Caterina Elia,
  • Lara Mussolin,
  • Salvatore Buffardi,
  • Marta Pillon,
  • Paola Muggeo,
  • Tommaso Casini and
  • Valli De Re
  • + 2 authors

31 August 2022

Classical pediatric Hodgkin Lymphoma (HL) is a rare malignancy. Therapeutic regimens for its management may be optimized by establishing treatment response early on. The aim of this study was to identify plasma protein biomarkers enabling the predict...

  • Article
  • Open Access
1,720 Views
23 Pages

Potential Molecular Biomarkers of Preeclampsia—A Pilot Study

  • Anna Romała,
  • Eliza Matuszewska-Mach,
  • Wiesław Markwitz,
  • Maciej Brązert,
  • Paulina Borysewicz,
  • Dagmara Pietkiewicz,
  • Jan Matysiak,
  • Krzysztof Drews and
  • Agata Szpera

Preeclampsia, one of the leading causes of maternal and fetal morbidity and mortality, affects approximately 3–5% of pregnancies worldwide. However, its etiology remains poorly understood. The aim of this study was to identify molecular markers...

  • Article
  • Open Access
2,362 Views
12 Pages

Neuronal Hyperactivation in EEG Data during Cognitive Tasks Is Related to the Apolipoprotein J/Clusterin Genotype in Nondemented Adults

  • Natalya V. Ponomareva,
  • Tatiana V. Andreeva,
  • Maria S. Protasova,
  • Svetlana S. Kunizheva,
  • Irina L. Kuznetsova,
  • Ekaterina P. Kolesnikova,
  • Daria D. Malina,
  • Andrey A. Mitrofanov,
  • Vitaly F. Fokin and
  • Evgeny I. Rogaev

The clusterin (CLU) rs11136000 CC genotype is a probable risk factor for Alzheimer’s disease (AD). CLU, also known as the apolipoprotein J gene, shares certain properties with the apolipoprotein E (APOE) gene with a well-established relationshi...

  • Article
  • Open Access
14 Citations
3,765 Views
13 Pages

Plasma Osteopontin Levels is Associated with Biochemical Markers of Kidney Injury in Patients with Leptospirosis

  • Haorile Chagan-Yasutan,
  • Firmanto Hanan,
  • Toshiro Niki,
  • Gaowa Bai,
  • Yugo Ashino,
  • Shinichi Egawa,
  • Elizabeth Freda O. Telan and
  • Toshio Hattori

: Leptospirosis becomes severe, with a fatality rate of >10%, and manifests as severe lung injury accompanied by acute kidney injury. Using urine and blood samples of 112 patients with leptospirosis, osteopontin (OPN), galectin-9 (Gal-9) and other...

  • Article
  • Open Access
3 Citations
3,029 Views
16 Pages

22 September 2022

We hypothesized that the persistent depletion of neuroprotective markers accompanies neuroinflammation and neurodegeneration in patients after cardiac surgery. A total of 158 patients underwent elective heart surgery with their blood collected before...

  • Article
  • Open Access
3 Citations
2,447 Views
20 Pages

Universal First-Trimester Screening Biomarkers for Diagnosis of Preeclampsia and Placenta Accreta Spectrum

  • Angelika V. Timofeeva,
  • Ivan S. Fedorov,
  • Alla M. Tarasova,
  • Yuliya V. Sukhova,
  • Vyacheslav G. Kolod’ko,
  • Tatiana Yu. Ivanets and
  • Gennady T. Sukhikh

4 February 2025

Background: Disruptions in epigenetic mechanisms regulating placentation, particularly imbalances in the levels of small non-coding RNAs, contribute to various pregnancy complications, including preeclampsia (PE) and placenta accreta spectrum (PAS)....

  • Article
  • Open Access
1,478 Views
19 Pages

Biomarkers for Early Detection of Cisplatin-Induced Nephrotoxicity

  • Nikolay Dimov,
  • Antoniya Yaneva,
  • Evelina Valcheva,
  • Gabriela Raycheva,
  • Veselin Popov,
  • Raya Delipavlova,
  • Dimitar Nikolov and
  • Zhanet Grudeva-Popova

12 September 2025

Nephrotoxicity is a common complication during antineoplastic therapy, particularly when platinum-based medications are used. Early detection of this condition is crucial for improving risk stratification and management, thereby enhancing decision-ma...

  • Article
  • Open Access
2 Citations
1,228 Views
16 Pages

Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide

  • Christodoulos Keskinis,
  • Eleni Moysidou,
  • Stamatia Stai,
  • Michalis Christodoulou,
  • Georgios Lioulios,
  • Sotirios-Spyridon Vamvakas,
  • Maria Stella Trivyza,
  • Panagiotis Pateinakis,
  • Marios Papasotiriou and
  • Maria Stangou

26 April 2025

Background & Objectives: Targeted-release budesonide (TRB) is the first approved agent aimed at targeting the early pathogenetic cascade in IgA nephropathy (IgAN). Materials and Methods: This prospective study included Caucasian IgAN patients dia...

  • Article
  • Open Access
4 Citations
3,723 Views
30 Pages

11 January 2023

The cellular response to environmental stresses, such as heat and oxidative stress, is dependent on extensive trafficking of stress-signalling molecules between the cytoplasm and nucleus, which potentiates stress-activated signalling pathways, eventu...

of 3